PureHealth Reports $5.5 Billion Revenue Amid Global Expansion

PureHealth has announced a revenue of $5.47 billion for the first nine months of the year, reflecting a 6 percent increase compared to the previous period. This growth is attributed to robust performance in its healthcare and insurance sectors, as well as its expansion into European markets. The company's earnings before interest, taxes, depreciation, and amortization (EBITDA) rose by 11 percent, reaching AED 3.5 billion (approximately $952.8 million). Additionally, net profit increased by 8 percent to AED 1.55 billion (around $422 million). These financial results underscore the effectiveness of PureHealth's integrated business model. A significant factor contributing to this growth was the completion of the acquisition of Hellenic Healthcare Group (HHG) in the third quarter, valued at €800 million (AED 3.1 billion or $846.6 million). This acquisition enhances PureHealth's international presence by adding 11 hospitals and 23 diagnostic centers in Greece and Cyprus, thereby bolstering its clinical, operational, and research capabilities across various global markets. The Chairman of PureHealth noted that these results highlight the strength of the group's integrated approach and long-term vision. The company is committed to ongoing expansion and investment in digital and clinical capabilities, which are seen as essential for sustainable growth. The Group CEO emphasized the progress made in scaling the company's network and enhancing its global reach. She pointed out that the growth was driven by effective execution in both the Care and Cover segments, with increased patient engagement and strong insurance renewals. With 52 percent of its assets now located outside the UAE, PureHealth is poised to further expand its global footprint, deepen its clinical specialization, and accelerate the development of AI-driven healthcare solutions. The group remains focused on delivering sustainable growth and long-term value for its patients, partners, and shareholders.

---